Fig. 2From: Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncologyRepresentative HPLC radiochromatograms for a [111In]In-AU-SAR-M1—radiochemical purity: 91%, b [111In]In-AU-SAR-M2—radiochemical purity: 96%, (c) [111In]In-AU-SAR-M3—radiochemical purity: 94%Back to article page